No Data
No Data
Jenkem Technology's Unit Completes Enrollment of First Subject for Polyethylene Glycol Irinotecan for Injection Trial
Jenkem Technology Enrolls First Subject for Phase III Trial of Lung Cancer Drug; Shares Jump 13%
Is Jenkem Technology Co., Ltd.'s (SHSE:688356) Recent Stock Performance Influenced By Its Fundamentals In Any Way?
After the Recent Decline, Jenkem Technology Co., Ltd. (SHSE:688356) CEO Xuan Zhao's Holdings Have Lost 11% of Their Value
Is It Smart To Buy Jenkem Technology Co., Ltd. (SHSE:688356) Before It Goes Ex-Dividend?
Jenkem Technology Co., Ltd.'s (SHSE:688356) Share Price Matching Investor Opinion